NYSE · Healthcare · Medical Devices · USA
Boston Scientific Corp is a large cap company (market value between $10 billion and $200 billion) in the Medical Devices industry.
Boston Scientific develops, manufactures and markets medical devices used across interventional medical specialties including cardiology, endoscopy, urology, neuromodulation and oncology. The company serves physicians and medical professionals globally with solutions for diagnosing and treating cardiovascular, respiratory, digestive, oncological, neurological and urological diseases. Its portfolio encompasses minimally invasive devices and therapies organized into two segments: MedSurg and Cardiovascular.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Boston Scientific Corp stock.
Undervalued: intrinsic value $63.49 per share, market price $45.05, margin of safety 29.0% (as of 2026-10-19).
Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $63.49; the price of $45.05 is 29% below that value, and 80% of that value comes from beyond year five.
Leak Score: 77/100 on 12 of 12 signals (Clear Leak).
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
3 more in this industry show a wider margin of safety.
BSX is undervalued (as of the 2026-10-19 close). Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $63.49; the price of $45.05 is 29% below that value, and 80% of that value comes from beyond year five.
$63.49 per share (as of the 2026-10-19 close), against a market price of $45.05. That is a margin of safety of 29.0%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
The price asks for less growth than the company has already delivered. Repeating its past would be enough. Yearly sales growth the price needs: 6.3%. Yearly sales growth it has sustained: 17.6%.
77 out of 100, which we rate "Clear Leak", on 12 of 12 value investing signals.